| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/18/1999 | WO1999007668A1 Non-steroidal ligands for the estrogen receptor |
| 02/18/1999 | WO1999007406A1 C1q AND COLLECTIN RECEPTOR |
| 02/18/1999 | WO1999007402A1 METHOD TO PREVENT ACCELERATED ATHEROSCLEROSIS USING (sRAGE) SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS |
| 02/18/1999 | WO1999007400A1 Dietary supplements containing natural ingredients |
| 02/18/1999 | WO1999007382A1 Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases |
| 02/18/1999 | WO1999007365A1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 02/18/1999 | WO1999007354A2 Compositions, apparatus and methods for facilitating surgical procedures |
| 02/18/1999 | WO1999007351A2 Indole derivatives and their use as mcp-1 antagonists |
| 02/18/1999 | WO1998051348A3 Sustained-release delayed gels |
| 02/18/1999 | WO1998033491A3 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
| 02/18/1999 | CA2301669A1 Peptides having potassium channel opener activity |
| 02/18/1999 | CA2300977A1 Neutral sphingomyelinase |
| 02/18/1999 | CA2300478A1 Selective factor xa inhibitors |
| 02/18/1999 | CA2299467A1 Method to prevent accelerated atherosclerosis using (srage) soluble receptor for advanced glycation endproducts |
| 02/18/1999 | CA2299286A1 Bicyclic compounds as ligands for 5-ht1 receptors |
| 02/18/1999 | CA2298849A1 Lipoprotein-regulating medicaments |
| 02/18/1999 | CA2298824A1 Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases |
| 02/18/1999 | CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | CA2297412A1 Anthranilic acid analogs |
| 02/18/1999 | CA2297409A1 Anthranilic acid analogs |
| 02/18/1999 | CA2297290A1 Chemical compounds |
| 02/18/1999 | CA2295535A1 Indole derivatives as mcp-1 receptor antagonists |
| 02/18/1999 | CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0897001A1 Polypeptide having a GTPase regulator activity, nucleic acids coding therefore and their use in diagnostics and therapy |
| 02/17/1999 | EP0896822A1 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 02/17/1999 | EP0896533A2 Pentafluorobenzenesulfonamides and analogs |
| 02/17/1999 | EP0896530A1 Dosage forms and uses |
| 02/17/1999 | EP0516777B1 Brain resuscitation device |
| 02/17/1999 | CN1208418A Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208417A Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208415A Angiogenesis inhibiting pyridazinamines |
| 02/17/1999 | CN1208409A Novel benzoyl guanidine derivatives process for their preparation and their use in the preparation of medicines |
| 02/17/1999 | CN1208035A Dithiolan derivatives, their preparation and their therapeutic effect |
| 02/17/1999 | CN1207925A Blood pressure depressing Yongquan plaster |
| 02/17/1999 | CN1207918A Application of theachrome in preparing medicine for viral myocarditis |
| 02/17/1999 | CN1207914A Application of theachrome in preparing medicine for thromboangiitis obliterans |
| 02/16/1999 | US5872280 Respiratory system disorders |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | US5872140 Vitamin D analogues |
| 02/16/1999 | US5872135 Enzyme inhibitors |
| 02/16/1999 | US5872134 Antiarrthmia, stroke, central nervous systems, schizophrenia |
| 02/16/1999 | US5872130 Quinoline type mevalonoactones |
| 02/16/1999 | US5872115 Compounds for treatment of hypercholesterolemia, ischemic heart disease, cerebrovascular disease or atherosclerosis |
| 02/16/1999 | US5871775 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance |
| 02/16/1999 | US5871766 Beta-carotene vitamin E therapy for inhibition of major vascular events |
| 02/16/1999 | US5871729 Superoxide dismutase-4 |
| 02/16/1999 | CA2122112C Adrenomedullin |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006437A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006432A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006431A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006410A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 02/11/1999 | WO1999006408A1 New 2,3-benzodiazepine derivatives |
| 02/11/1999 | WO1999006397A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | WO1999006395A1 Pyridyl- and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006367A1 Caspases and apoptosis |
| 02/11/1999 | WO1999006354A1 Il-8 receptor antagonists |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006070A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 02/11/1999 | WO1999006053A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | WO1999006051A1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 02/11/1999 | WO1999006049A1 Integrin receptor antagonists |
| 02/11/1999 | WO1999006042A1 Caspases and apoptosis |
| 02/11/1999 | WO1999006039A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols |
| 02/11/1999 | WO1999006035A2 COMBINATIONS OF HMG-CoA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT |
| 02/11/1999 | WO1999006025A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 02/11/1999 | WO1998050057A3 Agent for enhancing the heart force |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298668A1 Caspases and apoptosis |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2298544A1 Integrin receptor antagonists |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2297988A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 02/11/1999 | CA2297894A1 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | CA2297757A1 Caspases and apoptosis |
| 02/11/1999 | CA2296485A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | CA2294064A1 Il-8 receptor antagonists |
| 02/11/1999 | CA2290750A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290749A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290748A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290747A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/10/1999 | EP0896003A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 02/10/1999 | EP0895475A1 Vitronectin receptor antagonists |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | EP0659174B1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |